Literature DB >> 19685103

18F-FDG PET successfully detects spinal cord sarcoidosis.

Kiyobumi Ota, Taiji Tsunemi, Kazuyoshi Saito, Fumika Yamanami, Mutsufusa Watanabe, Takashi Irioka, Hidehiro Mizusawa.   

Abstract

Though there has been an array of methods to evaluate the extent of sarcoidosis, it is generally difficult to detect central nervous system involvement. Recently it has become accepted that 18F-FDG PET is more sensitive than gallium scintigraphy in finding sarcoid lesions, however its usefulness and limitations for detecting sarcoidosis in the central nervous system, especially in the spinal cord, has rarely been investigated. Two patients with pathologically confirmed sarcoidosis manifested spinal symptoms. We conducted 18F-FDG PET along with conventional imagings before and after treatment. Abnormal FDG uptakes which could not be detected by gallium scintigraphy were shown in the spinal cords in both patients. These abnormal uptakes were diminished in accordance with clinical improvement after treatment. Our findings suggest that 18F-FDG PET is effective in detecting and tracking the activity of spinal sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19685103     DOI: 10.1007/s00415-009-5270-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis.

Authors:  S B Sulavik; R P Spencer; D A Weed; H R Shapiro; S T Shiue; R J Castriotta
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

2.  Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy.

Authors:  Yan Xiu; Jian Q Yu; Edgar Cheng; Rakesh Kumar; Abass Alavi; Hongming Zhuang
Journal:  Clin Nucl Med       Date:  2005-03       Impact factor: 7.794

Review 3.  Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis.

Authors:  Eli M Baron; William F Young
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

4.  Interpretation of the 67 Ga photoscan.

Authors:  S M Larson; M S Milder; G S Johnston
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

Review 5.  Pitfalls in the diagnosis of brain tumours.

Authors:  Antonio Mp Omuro; Claudia C Leite; Karima Mokhtari; Jean-Yves Delattre
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

Review 6.  Neurosarcoidosis: a clinical dilemma.

Authors:  Elske Hoitsma; Carin G Faber; Marjolein Drent; Om P Sharma
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

Review 7.  Sarcoidosis and malignancy.

Authors:  Philip R Cohen; Razelle Kurzrock
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

Review 8.  Clinical applications of PET in oncology.

Authors:  Eric M Rohren; Timothy G Turkington; R Edward Coleman
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

9.  Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.

Authors:  N Aide; M Benayoun; K Kerrou; A Khalil; J Cadranel; J N Talbot
Journal:  Br J Radiol       Date:  2007-03       Impact factor: 3.039

10.  Central nervous system sarcoidosis--diagnosis and management.

Authors:  J P Zajicek; N J Scolding; O Foster; M Rovaris; J Evanson; I F Moseley; J W Scadding; E J Thompson; V Chamoun; D H Miller; W I McDonald; D Mitchell
Journal:  QJM       Date:  1999-02
View more
  7 in total

Review 1.  Recent advances in spinal cord neurology.

Authors:  Volker Dietz
Journal:  J Neurol       Date:  2010-08-18       Impact factor: 4.849

2.  Regional impairment of 18F-FDG uptake in the cervical spinal cord in patients with monosegmental chronic cervical myelopathy.

Authors:  Frank Willi Floeth; Gabriele Stoffels; Jörg Herdmann; Paul Jansen; Wolfgang Meyer; Hans-Jakob Steiger; Karl-Josef Langen
Journal:  Eur Radiol       Date:  2010-07-20       Impact factor: 5.315

3.  The normal variant (18)F FDG uptake in the lower thoracic spinal cord segments in cancer patients without CNS malignancy.

Authors:  Geetika Bhatt; Xiao-Feng Li; Angita Jain; Vivek R Sharma; Jianmin Pan; Archana Rai; Shesh Nath Rai; A Cahid Civelek
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-07-10

4.  Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.

Authors:  Ken Sakushima; Ichiro Yabe; Fumihito Nakano; Kazuto Yoshida; Yasutaka Tajima; Hideki Houzen; Yasunori Maruo; Hidenao Sasaki
Journal:  J Neurol       Date:  2011-05-07       Impact factor: 4.849

5.  FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.

Authors:  Ken Sakushima; Ichiro Yabe; Tohru Shiga; Moemi Yashima-Yamada; Sachiko Tsuji-Akimoto; Satoshi Terae; Hidenao Sasaki
Journal:  J Neurol       Date:  2010-09-05       Impact factor: 4.849

6.  Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients.

Authors:  Cécile-Audrey Durel; Romain Marignier; Delphine Maucort-Boulch; Jean Iwaz; Emilie Berthoux; Marc Ruivard; Marc André; Guillaume Le Guenno; Laurent Pérard; Jean-François Dufour; Alin Turcu; Jean-Christophe Antoine; Jean-Philippe Camdessanche; Thierry Delboy; Pascal Sève
Journal:  J Neurol       Date:  2016-03-23       Impact factor: 4.849

7.  Changes in (18)f-fluorodeoxyglucose uptake in the spinal cord in a healthy population on serial positron emission tomography/computed tomography.

Authors:  Ari Chong; Ho-Chun Song; Byung-Hyun Byun; Sun-Pyo Hong; Jung-Joon Min; Hee-Seung Bom; Jung-Min Ha; Jung-Kil Lee
Journal:  Chonnam Med J       Date:  2013-04-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.